NCT07583329

Brief Summary

Endometrial cancer is a common cancer in women, and surgery is usually the first step in treatment. During surgery, doctors often check nearby lymph nodes to see if the cancer has spread. A newer method called sentinel lymph node (SLN) mapping allows doctors to examine only the first few lymph nodes most likely to contain cancer. This can reduce the need for removing many lymph nodes and may lower the risk of complications. Minimally invasive surgery is commonly performed using small abdominal incisions (laparoscopy). A newer technique, called vaginal natural orifice transluminal endoscopic surgery (vNOTES), allows the surgery to be performed through the vagina without any cuts on the abdomen. This approach may lead to less pain, quicker recovery, and no visible scars. This study will compare these two surgical methods-laparoscopy and vNOTES-in patients with early-stage endometrial cancer. Researchers will look at how safe and effective each method is, how patients recover after surgery, and how well the sentinel lymph node procedure works with each technique. The study will also examine how quickly surgeons become experienced with the newer vNOTES method. The goal of this research is to determine whether vNOTES can be a safe and effective alternative to standard laparoscopic surgery, while offering potential benefits for patients.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
121mo left

Started May 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

May 19, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2028

Expected
8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2036

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

April 22, 2026

Last Update Submit

May 18, 2026

Conditions

Keywords

v-notessentinel lymph nodeconventional laparoscopy

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Sentinel Lymph Node Detection Rates in Endometrial Cancer Cases Performed with V-NOTES and Conventional Laparoscopy

    Baseline (pre-procedure), perioperative/periprocedural period

Secondary Outcomes (4)

  • The Relationship Between Case Volume and the Learning Curve of Surgeons for Sentinel Lymph Node Procedures in Endometrial Cancer Cases Performed with V-NOTES and Conventional Laparoscopy

    Baseline (pre-procedure), perioperative/periprocedural period

  • The Impact of Sentinel Lymph Node Applications on Progression-Free Survival in Endometrial Cancer Cases Performed with V-NOTES and Conventional Laparoscopy

    up to 5 years

  • The Impact of Sentinel Lymph Node Applications on Overall Survival in Endometrial Cancer Cases Performed with V-NOTES and Conventional Laparoscopy

    Up to 10 years

  • Evaluation of Surgical Complications in Endometrial Cancer Cases Performed with V-NOTES and Conventional Laparoscopy

    Baseline (pre-procedure), perioperative/periprocedural period

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Histologically confirmed endometrial cancer on preoperative endometrial biopsy

You may qualify if:

  • Age ≥18 years
  • Histologically confirmed endometrial cancer on preoperative endometrial biopsy
  • Disease confirmed to be confined to the uterus based on clinical evaluation and imaging
  • No evidence of lymphatic or distant metastasis on positron emission tomography/computed tomography(PET/CT) or magnetic resonance imaging (MRI)
  • Surgical staging with sentinel lymph node biopsy recommended by a multidisciplinary tumor board
  • Surgical treatment performed using either conventional laparoscopy or the vNOTES approach

You may not qualify if:

  • Presence of extrauterine disease
  • Detection of distant metastasis
  • Surgery performed via an open (laparotomy) approach
  • Incomplete medical records
  • History of prior pelvic radiotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova Univercity

Adana, 01000, Turkey (Türkiye)

Location

Related Publications (3)

  • Odgers H, Lin A, Tejada-Berges T. Comparison of laparoscopic vs. robotic sentinel lymph node mapping and biopsy in endometrial cancer. J Robot Surg. 2025 Apr 24;19(1):173. doi: 10.1007/s11701-025-02300-w.

    PMID: 40272600BACKGROUND
  • Baekelandt J, Jespers A, Huber D, Badiglian-Filho L, Stuart A, Chuang L, Ali O, Burnett A. vNOTES retroperitoneal sentinel lymph node dissection for endometrial cancer staging: First multicenter, prospective case series. Acta Obstet Gynecol Scand. 2024 Jul;103(7):1311-1317. doi: 10.1111/aogs.14843. Epub 2024 Apr 16.

    PMID: 38623778BACKGROUND
  • Nadaban M, Balint O, Secosan C, Furau AM, Olaru F, Pirtea L. V-Notes Sentinel Lymph Node Staging for Endometrial Cancer: A Systematic Review. J Clin Med. 2025 Sep 12;14(18):6451. doi: 10.3390/jcm14186451.

    PMID: 41010655BACKGROUND

MeSH Terms

Conditions

Endometrial Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

April 22, 2026

First Posted

May 13, 2026

Study Start

May 19, 2026

Primary Completion (Estimated)

April 30, 2028

Study Completion (Estimated)

April 30, 2036

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations